Amgen AMGN reported first-quarter adjusted earnings of $5.15 per share, which beat the Zacks Consensus Estimate of $4.73 per ...

Amgen has launched a late-stage program to test the feasibility of switching patients from weekly GLP-1 injections to its own ...

Osteoarthritis has no cure, but researchers have developed new therapies that help aging or damaged joints repair themselves ...

Good afternoon, everyone, and welcome to our first quarter of 2026 earnings call. Bob Bradway will lead the call today and be followed by a broader review of our performance by Murdo Gordon, Jay ...

Amgen Inc. reported better-than-expected first-quarter results but only minimally raised its profit guidance, a conservative move as the biotechnology company prepares for increasing competition over ...

Abstract: This letter substantially improves the understanding on the degradation of normally-OFF GaN HEMTs with p-GaN gate subject to forward gate stress, and demonstrates that a significant ...

Also, since I have a history of dental problems, how can I get off Prolia in the future and still protect my bones? -- L.L.